A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases
Condition(s):Brain Metastases, AdultLast Updated:February 14, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Brain Metastases, AdultLast Updated:February 14, 2024Not yet recruiting
Condition(s):Non-Small Cell Lung Carcinoma; Advanced Non-Small Cell Squamous Lung Cancer; EGFR Gene MutationLast Updated:February 1, 2024Not yet recruiting
Condition(s):Metastatic Breast Cancer; Locally Advanced Breast CancerLast Updated:January 24, 2024Recruiting
Condition(s):Non-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorLast Updated:January 29, 2024Active, not recruiting
Condition(s):Nonsquamous Non-small Cell Lung Cancer; EGFR L858R; EGFR Exon 19 DeletionLast Updated:January 11, 2024Active, not recruiting
Condition(s):Non-Small Cell Lung Cancer (NSCLC)Last Updated:January 17, 2024Recruiting
Condition(s):Breast CancerLast Updated:September 21, 2023Active, not recruiting
Condition(s):Metastatic Breast Cancer; Advanced Non-Small Cell Squamous Lung Cancer; Solid Tumor, AdultLast Updated:February 16, 2024Recruiting
Condition(s):Metastatic Breast CancerLast Updated:May 18, 2023Recruiting
Condition(s):Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerLast Updated:March 5, 2024Available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.